Large Molecule Biologics Development
Product Description
Resilience
-
Country/Region:United States
-
Founded:2020
-
On CPHI since:2023
-
Certificates:4
-
Employees:1000 - 4999
Company types
Primary activities
Categories
Specifications
Resilience
-
Country/Region:United States
-
Founded:2020
-
On CPHI since:2023
-
Certificates:4
-
Employees:1000 - 4999
Company types
Primary activities
More Products from Resilience (4)
-
Product Device Assembly, Packaging & Logistics
Device platforms: autoinjector, accessorized prefilled syringe, and cartridge assembly, supporting APFS, Ypsomed, and SHL platforms, plus additional device and proprietary platforms [TK: confirm current platform list]
Packaging: labeling, serialization, and aggregation across bulk, multi-u... -
Product Drug Substance Manufacturing
Modalities: monoclonal antibodies, recombinant proteins (including complex and non-cytotoxic conjugated), fusion proteins, enzymes, bispecifics, and plasma proteins
Scale: single-use bioreactors 3L to 500L (development) and 50L to 2,000L (manufacturing)
Stage coverage: pre... -
Product Parenteral Drug Product Manufacturing
Parenteral Formats: vials, accessorized prefilled syringes, autoinjectors, pen injectors, and cartridges
Formulation: parenteral aseptic liquid, including adjuvant, suspension, and other complex presentations
Finishing: 100% visual inspection, device assembly, packaging, s... -
Product Sterile Fill/Finish
Formats: vials, pre-filled syringes, and cartridges
Fill technology: isolator- and RABS-based automated and semi-automated lines
Sites: Toronto and Cincinnati, both commercially licensed
Stage coverage: clinical and commercial, GMP and non-GMP
...



